BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, ...

Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic ...

Dr. Laila El-Khattabi (Sorbonne University Hospitals and the Brain Institute, Paris, France) will share results from the CHROMAPS project, a multi-institutional European collaboration utilizing OGM to ...

New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of motor function in a broad population of ...

A new exhibition in New York brings together a diverse collection of posters reflecting the opposing ideologies surrounding ...

"We are pleased to be sharing several new analyses relating to aficamten at the upcoming ACC Scientific Session & Expo,” said ...

The answer to your heart health may be on your wrist, a new study suggests. Researchers have developed a new way to assess ...

Rising high school students from across New Jersey converged for the annual New Jersey Southern Junior Science and Humanities ...

Cytokinetics (CYTK) announced five presentations related to aficamten, an investigational cardiac myosin inhibitor, and hypertrophic ...

Aluminum had already dealt with its share of bad press—researchers in the 60s and 70s noticed that Alzheimer's disease ...

"What a boon this will be to downtown Topeka," said Janet Stanek, the KDHE secretary, of the new Kansas health and ...